Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review Lauro Fabián Amador-Medina; Erick Crespo-Solís; Francisco Javier Turrubiates-Hernández; Karla Edith Santibañez-Bedolla;

Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up Kaira Mara Cordeiro de Albuquerque; Caroline Brandão Joventino; Lia Correia Moreira; Hermano Alexandre Lima Rocha; Lívia Andrade Gurgel; Deivide de Sousa Oliveira; Carlos Ewerton Maia Rodrigues;

Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia Aline do Nascimento; Daniel da Silva Pereira Curado; Thais Montezuma; Wallace Breno Barbosa; Juliana Machado-Rugolo; Mariana Millan Fachi;